In case you missed it: July 25 to July 29

Article

A look back at this week's news.

Placental cord drainage may be simpler, more effective than standard practice

Placental cord drainage may be the key to managing the third stage of labor, according to research in BMC Pregnancy and Childbirth.

RVVC treatment drug oteseconazole now commercially available in US

Mycovia Pharmaceuticals recently announced US availability of oteseconazole capsules for the treatment of recurrent vulvovaginal candidiasis in women without reproductive potential.

Fezolinetant making waves for VMS

Genevieve Neal-Perry, MD, PhD, sits down with Contemporary OB/GYN to discuss positive data from a recent phase 3 study evaluating fezolinetant (Astellas) for vasomotor symptoms (VMS).

Clinical considerations for monkeypox in pregnancy

What we know about monkeypox in pregnancy, including treatment recommendations, vaccination, and postpartum care.

COVID-19 pregnancy data in the United States: July 25 update

Data on COVID-19 during pregnancy, as reported by the CDC, in collaboration with state, local, and territorial health departments and external partners.

ObsEva drops linzagolix, focuses on prospects for preterm labor, IVF

ObsEva plans to drop linzagolix, its leading candidate for the treatment of uterine fibroids, following concerns raised by the FDA.

Related Videos
Navigating vasomotor symptoms in breast cancer patients | Image Credit: menopausefoundationcanada.ca.
Fertility counseling for oncology patients | Image Credit: allhealthtv.com
Learning what women prefer in STI preventive care
The impact of smoking cessation on pregnancy outcomes | Image Credit: rwjmg.rwjms.rutgers.edu
USPSTF releases new recommendations for breast cancer screening | Image Credit: uclahealth.org
Maximizing maternal health: The impact of exercise during pregnancy | Image Credit: cedars-sinai.org
Understanding combined oral contraceptives and breast cancer risk | Image Credit: health.ucdavis.edu
Why doxycycline PEP lacks clinical data for STI prevention in women
© 2024 MJH Life Sciences

All rights reserved.